Average Co-Inventor Count = 5.00
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Centocor, Inc. (38 from 144 patents)
2. New York University (32 from 1,616 patents)
3. Other (4 from 831,952 patents)
4. The United States of America As Represented by the Department of Health (2 from 1,215 patents)
5. Cna Development LLC (1 from 1 patent)
45 patents:
1. 7744885 - Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof
2. 7718176 - Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
3. 7425330 - Methods of inhibiting TNFα activity in the blood of a patient
4. 7416729 - Methods of treating rheumatoid arthritis with anti-TNF antibodies
5. 7404955 - Methods of inhibiting or neutralizing TNFα in patients with tissue injury
6. 7393662 - Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
7. 7374761 - Recombinant A2-specific TNFα-specific antibodies
8. 7335358 - Methods of treating psoriasis with anti-TNF antibodies
9. 7276239 - Recombinant A2-specific TNFα-specific antibodies
10. 7252823 - Recombinant A2-specific TNFα-specific antibodies
11. 7241733 - Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
12. 7227003 - Anti-TNF antibody fragments
13. 7226593 - Methods of treating cachexia with chimeric anti-TNF antibodies
14. 7223396 - Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies
15. 7214376 - Methods of inhibiting TNFα in patients with neoplastic disease